|
1 | 1 | <?xml version="1.0" encoding="UTF-8"?> |
2 | 2 | <ProteinModifications> |
3 | 3 | <Revisions> |
4 | | - <Revision> |
5 | | - <Date>2016-05-10</Date> |
6 | | - <Change>Added definition for PLP</Change> |
7 | | - <Date>2011-08-12</Date> |
8 | | - <Change>Added glycosylation entries 386-429</Change> |
| 4 | + <Revision> |
| 5 | + <Date>2016-06-10</Date> |
| 6 | + <Change>Updated legacy chemical component and atom names to current naming conventions. Removed two obsolete entires (CLE and CGL)</Change> |
| 7 | + </Revision> |
| 8 | + <Revision> |
| 9 | + <Date>2016-05-10</Date> |
| 10 | + <Change>Added definition for PLP</Change> |
| 11 | + <Date>2011-08-12</Date> |
| 12 | + <Change>Added glycosylation entries 386-429</Change> |
9 | 13 | </Revision> |
10 | 14 | <Revision> |
11 | 15 | <Date>2011-07-26</Date> |
|
730 | 734 | <SystematicName>(R)-2-amino-3-selanylpropanoic acid</SystematicName> |
731 | 735 | <CrossReference> |
732 | 736 | <Source>PDBCC</Source> |
733 | | - <Id>CSE</Id> |
| 737 | + <Id>SEC</Id> |
734 | 738 | <Name>selenocysteine</Name> |
735 | 739 | </CrossReference> |
736 | 740 | <CrossReference> |
|
745 | 749 | </CrossReference> |
746 | 750 | <Condition> |
747 | 751 | <Component component="1"> |
748 | | - <Id source="PDBCC">CSE</Id> |
| 752 | + <Id source="PDBCC">SEC</Id> |
749 | 753 | </Component> |
750 | 754 | </Condition> |
751 | 755 | <Occurrence>natural</Occurrence> |
|
1353 | 1357 | <Category>modified residue</Category> |
1354 | 1358 | <Keyword>amidated carboxyl end</Keyword> |
1355 | 1359 | </Entry> |
1356 | | - <Entry> |
1357 | | - <Id>0045</Id> |
1358 | | - <Description>A protein modification that effectively converts an L-leucine residue to L-leucine amide.</Description> |
1359 | | - <SystematicName>(S)-2-amino-4-methylpentanamide</SystematicName> |
1360 | | - <CrossReference> |
1361 | | - <Source>PDBCC</Source> |
1362 | | - <Id>CLE</Id> |
1363 | | - <Name>leucine amide</Name> |
1364 | | - </CrossReference> |
1365 | | - <CrossReference> |
1366 | | - <Source>RESID</Source> |
1367 | | - <Id>AA0091</Id> |
1368 | | - <Name>L-leucine amide</Name> |
1369 | | - </CrossReference> |
1370 | | - <CrossReference> |
1371 | | - <Source>PSI-MOD</Source> |
1372 | | - <Id>MOD:00100</Id> |
1373 | | - <Name>L-leucine amide</Name> |
1374 | | - </CrossReference> |
1375 | | - <Condition> |
1376 | | - <Component component="1"> |
1377 | | - <Id source="PDBCC">CLE</Id> |
1378 | | - <Terminal>C</Terminal> |
1379 | | - </Component> |
1380 | | - </Condition> |
1381 | | - <Occurrence>natural</Occurrence> |
1382 | | - <Category>modified residue</Category> |
1383 | | - <Keyword>amidated carboxyl end</Keyword> |
1384 | | - </Entry> |
1385 | 1360 | <Entry> |
1386 | 1361 | <Id>0046</Id> |
1387 | 1362 | <Description>A protein modification that effectively converts an L-phenylalanine residue to L-phenylalanine amide.</Description> |
|
3755 | 3730 | <SystematicName>(R)-2-amino-2-carboxyethanesulfinic acid</SystematicName> |
3756 | 3731 | <CrossReference> |
3757 | 3732 | <Source>PDBCC</Source> |
3758 | | - <Id>CSW</Id> |
| 3733 | + <Id>CSD</Id> |
3759 | 3734 | <Name>cysteine-S-dioxide</Name> |
3760 | 3735 | </CrossReference> |
3761 | 3736 | <CrossReference> |
|
3770 | 3745 | </CrossReference> |
3771 | 3746 | <Condition> |
3772 | 3747 | <Component component="1"> |
3773 | | - <Id source="PDBCC">CSW</Id> |
| 3748 | + <Id source="PDBCC">CSD</Id> |
3774 | 3749 | </Component> |
3775 | 3750 | </Condition> |
3776 | 3751 | <Occurrence>natural</Occurrence> |
|
6788 | 6763 | <Id source="PDBCC">SEC</Id> |
6789 | 6764 | </Component> |
6790 | 6765 | <Bond> |
6791 | | - <Atom component="1">SEG</Atom> |
6792 | | - <Atom component="2">SEG</Atom> |
| 6766 | + <Atom component="1">SE</Atom> |
| 6767 | + <Atom component="2">SE</Atom> |
6793 | 6768 | </Bond> |
6794 | 6769 | </Condition> |
6795 | 6770 | <Occurrence>hypothetical</Occurrence> |
|
6997 | 6972 | </Component> |
6998 | 6973 | <Bond> |
6999 | 6974 | <Atom component="1">SG</Atom> |
7000 | | - <Atom component="2">SEG</Atom> |
| 6975 | + <Atom component="2">SE</Atom> |
7001 | 6976 | </Bond> |
7002 | 6977 | </Condition> |
7003 | 6978 | <Occurrence>natural</Occurrence> |
|
9629 | 9604 | <Occurrence>natural</Occurrence> |
9630 | 9605 | <Category>attachment</Category> |
9631 | 9606 | <Keyword>phosphoprotein</Keyword> |
9632 | | - </Entry> |
9633 | | - <Entry> |
9634 | | - <Id>0290</Id> |
9635 | | - <Description>A protein modification that effectively converts an L-cysteine residue to S-glutathionyl-L-cysteine.</Description> |
9636 | | - <SystematicName>(2S)-2-amino-3-((2S)-2-((4R)-4-amino-4-carboxyl-1-oxobutyl)amino-3-(carboxylmethyl)amino-3-oxo-propyl)dithio-propanoic acid</SystematicName> |
9637 | | - <CrossReference> |
9638 | | - <Source>PDBCC</Source> |
9639 | | - <Id>CGL</Id> |
9640 | | - <Name></Name> |
9641 | | - </CrossReference> |
9642 | | - <CrossReference> |
9643 | | - <Source>RESID</Source> |
9644 | | - <Id>AA0229</Id> |
9645 | | - <Name>L-cysteine glutathione disulfide</Name> |
9646 | | - </CrossReference> |
9647 | | - <CrossReference> |
9648 | | - <Source>PSI-MOD</Source> |
9649 | | - <Id>MOD:00234</Id> |
9650 | | - <Name>L-cysteine glutathione disulfide</Name> |
9651 | | - </CrossReference> |
9652 | | - <CrossReference> |
9653 | | - <Source>PDBCC</Source> |
9654 | | - <Id>CGL</Id> |
9655 | | - <Name>cystine-glutathione</Name> |
9656 | | - </CrossReference> |
9657 | | - <Condition> |
9658 | | - <Component component="1"> |
9659 | | - <Id source="PDBCC">CGL</Id> |
9660 | | - </Component> |
9661 | | - </Condition> |
9662 | | - <Occurrence>natural</Occurrence> |
9663 | | - <Category>modified residue</Category> |
9664 | | - <Keyword>disulfide bond</Keyword> |
9665 | 9607 | </Entry> |
9666 | 9608 | <Entry> |
9667 | 9609 | <Id>0291</Id> |
|
9983 | 9925 | <SystematicName>(2R)-2-amino-6-[(2R,3R)-3-methyl-3,4-dihydro-2H-pyrrol-2-ylcarbonyl]aminohexanoic acid</SystematicName> |
9984 | 9926 | <CrossReference> |
9985 | 9927 | <Source>PDBCC</Source> |
9986 | | - <Id>PYH</Id> |
| 9928 | + <Id>PYL</Id> |
9987 | 9929 | <Name>N6-{[(2R,3R)-3-methyl-3,4-dihydro-2H-pyrrol-2-yl]carbonyl}-L-lysine</Name> |
9988 | 9930 | </CrossReference> |
9989 | 9931 | <CrossReference> |
|
9998 | 9940 | </CrossReference> |
9999 | 9941 | <Condition> |
10000 | 9942 | <Component component="1"> |
10001 | | - <Id source="PDBCC">PYH</Id> |
| 9943 | + <Id source="PDBCC">PYL</Id> |
10002 | 9944 | </Component> |
10003 | 9945 | </Condition> |
10004 | 9946 | <Occurrence>natural</Occurrence> |
|
0 commit comments